In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 2.58 below Cytek Biosciences Inc average.

Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Quick Ratio than Cytek Biosciences Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 848 to 1157.

Explain Quick Ratio?
How much Cash & cash equivalents CTKB�s has?
What are CTKB�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CTKB/financial-strength

https://api.csimarket.com/api/v1/companies/CTKB/fundamentals

https://api.csimarket.com/api/v1/companies/CTKB/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CTKB Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	31.87 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-2.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	2.58	Subscribe	Subscribe	Subscribe	Subscribe
CTKB's Total Ranking	# 1157	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	6.99 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-2.33 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 8
Healthcare Sector	# 414
Overall Market	# 1157

Quick Ratio Statistics
High	Average	Low
18.65	7.02	2.83
(Dec 31 2021)		(Jun 30 2026)

Financial Statements
Cytek Biosciences Inc 's Current Liabilities	$ 99 Millions	Visit CTKB's Balance sheet
Cytek Biosciences Inc 's Cash & cash equivalent	$ 256 Millions	Visit CTKB's Balance sheet
Source of CTKB's Sales		Visit CTKB's Sales by Geography

Cumulative Cytek Biosciences Inc 's Quick Ratio

CTKB's Quick Ratio for the trailling 12 Months

CTKB Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	28.94 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-2.4 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	2.92	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 1241	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	7.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-0.56 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CTKB Financial Strength Comparisons >> Go to Compare CTKB Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $99.18 millions, cumulative Quick Ratio decreased to 2.92 below the Cytek Biosciences Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Cytek Biosciences Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3005 to 3950.

Explain Quick Ratio?
How much Cash & cash equivalents CTKB�s has?
What are CTKB�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 893
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
10.36	4.32	1.02
(Dec 31 2021)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc	6.77	$ 226.585 Millions	$ 33.482 Millions
Standard Biotools Inc	5.24	$ 267.487 Millions	$ 51.021 Millions
Eyepoint Inc	4.91	$ 189.113 Millions	$ 38.507 Millions
10x Genomics Inc	4.10	$ 575.725 Millions	$ 140.370 Millions
Pacific Biosciences Of California Inc	3.01	$ 200.217 Millions	$ 66.593 Millions
Seer Inc	2.95	$ 29.316 Millions	$ 9.942 Millions
Cytek Biosciences Inc	2.58	$ 255.899 Millions	$ 99.179 Millions
Quanterix Corporation	1.51	$ 77.359 Millions	$ 51.130 Millions
Nautilus Biotechnology Inc	1.07	$ 10.467 Millions	$ 9.758 Millions
Precipio inc	0.90	$ 3.576 Millions	$ 3.985 Millions
Bio rad Laboratories Inc	0.86	$ 837.100 Millions	$ 969.100 Millions
Bionano Genomics Inc	0.66	$ 8.168 Millions	$ 12.307 Millions
Revvity Inc	0.63	$ 592.799 Millions	$ 936.977 Millions

Date modified: 2026-11-06T13:05:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.